You are here

NIH

NIH advisors say data doesn't support plasma use for COVID-19

BioPharma Dive

Wed, 09/2/20 - 11:00 am

convalescent plasma

Alzheon returns, with a $47 million NIH grant and one last shot at a pivotal PhIII Alzheimer’s success

Endpoints

Thu, 08/20/20 - 10:43 am

Alzheimer's disease

Gilead's COVID med remdesivir is scarce and costly, AGs say, urging feds to sidestep its patents

Fierce Pharma

Wed, 08/5/20 - 11:14 pm

Gilead Sciences

Seven plucky diagnostics companies win a $249M round of contracts after surviving NIH's Covid-19 'Shark Tank' competition

Endpoints

Mon, 08/3/20 - 11:37 pm

Talis Biomedical

Ginkgo Bioworks

Mammoth Biosciences

Medical researchers sign open letter calling for COVID-19 human challenge trials

Beckers Hospital Review

Sat, 07/18/20 - 12:14 pm

clinical trials

NIH rolls out COVID-19 clinical trials network: 5 things to know

Beckers Hospital Review

Sat, 07/11/20 - 12:06 pm

clinical trials

COVID-19 Prevention Trials Network

Gilead Covid-19 drug remdesivir benefited from $6.5B in NIH-funded basic research, study finds

MedCity News

Fri, 07/10/20 - 10:49 am

Gilead Sciences

Former Sanofi research exec Zerhouni favorite for COVID-19 czar: report

Fierce Biotech

Mon, 05/11/20 - 10:29 am

Inside the NIH’s controversial decision to stop its big remdesivir study

Stat

Mon, 05/11/20 - 10:24 am

Gilead Sciences

clinical trials

After NIH trial, EMA begins rolling review for remdesivir, setting up potential authorizations in US and Europe

Endpoints

Thu, 04/30/20 - 10:43 pm

Gilead Sciences

A COVID-19 treatment inspired by llamas

Fierce Biotech

Thu, 04/30/20 - 10:16 pm

drug development

animal research

BARDA director abruptly departs agency tasked with leading nation's vaccine development

BioPharma Dive

Wed, 04/22/20 - 12:03 am

NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vaccines

Stat

Fri, 04/17/20 - 10:58 am

drug development

Simply speaking could transmit coronavirus, new study suggests

Stat

Wed, 04/15/20 - 11:24 pm

Eli Lilly teams with NIH, antibody upstart AbCellera in coronavirus hunt

Endpoints

Fri, 03/13/20 - 10:57 am

To develop a coronavirus vaccine, synthetic biologists try to outdo nature

Stat

Mon, 03/9/20 - 10:19 am

Gates Foundation

synthetic biology

US cancels trial after finding vaccine doesn't prevent HIV

BioPharma Dive

Mon, 02/3/20 - 11:43 pm

Moderna, federal researchers kick off vaccine work against deadly new coronavirus

Fierce Pharma

Wed, 01/22/20 - 11:12 pm

Moderna Therapeutics

Wuhan Coronavirus

New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics

Xtalks

Mon, 01/13/20 - 11:35 pm

multiple sclerosis

Will sky-high drug prices spur the US to use an obscure power over patents?

Biopharma Dive

Wed, 12/4/19 - 11:31 pm

Pages